WO2007035843A3 - Methods and compositions for organ and tissue functionality - Google Patents

Methods and compositions for organ and tissue functionality Download PDF

Info

Publication number
WO2007035843A3
WO2007035843A3 PCT/US2006/036750 US2006036750W WO2007035843A3 WO 2007035843 A3 WO2007035843 A3 WO 2007035843A3 US 2006036750 W US2006036750 W US 2006036750W WO 2007035843 A3 WO2007035843 A3 WO 2007035843A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
organ
compositions
cells
tissue functionality
Prior art date
Application number
PCT/US2006/036750
Other languages
French (fr)
Other versions
WO2007035843A2 (en
Inventor
Donald A Kleinsek
Adriana Soto
Original Assignee
Donald A Kleinsek
Adriana Soto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Donald A Kleinsek, Adriana Soto filed Critical Donald A Kleinsek
Priority to KR1020137013495A priority Critical patent/KR20130066707A/en
Priority to EP06803955A priority patent/EP1996013A4/en
Priority to CA002663749A priority patent/CA2663749A1/en
Priority to JP2008532366A priority patent/JP2009508650A/en
Priority to AU2006292203A priority patent/AU2006292203A1/en
Publication of WO2007035843A2 publication Critical patent/WO2007035843A2/en
Publication of WO2007035843A3 publication Critical patent/WO2007035843A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/10—Hair or skin implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

Materials and methods for treating tissue defects in human or animal tissues using implantable cells are described. Further, culture techniques and factors for enhancing these procedures, and cell survival and adaptation are described. Many of the tissue defects may be treated with autologous cells, while applications involving non-autologous cells or stem cells are also described.
PCT/US2006/036750 2005-09-21 2006-09-21 Methods and compositions for organ and tissue functionality WO2007035843A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
KR1020137013495A KR20130066707A (en) 2005-09-21 2006-09-21 Methods and compositions for organ and tissue functionality
EP06803955A EP1996013A4 (en) 2005-09-21 2006-09-21 Methods and compositions for organ and tissue functionality
CA002663749A CA2663749A1 (en) 2005-09-21 2006-09-21 Methods and compositions for organ and tissue functionality
JP2008532366A JP2009508650A (en) 2005-09-21 2006-09-21 Methods and compositions for organ and tissue function
AU2006292203A AU2006292203A1 (en) 2005-09-21 2006-09-21 Methods and compositions for organ and tissue functionality

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71974305P 2005-09-21 2005-09-21
US60/719,743 2005-09-21

Publications (2)

Publication Number Publication Date
WO2007035843A2 WO2007035843A2 (en) 2007-03-29
WO2007035843A3 true WO2007035843A3 (en) 2007-07-05

Family

ID=37889518

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/036750 WO2007035843A2 (en) 2005-09-21 2006-09-21 Methods and compositions for organ and tissue functionality

Country Status (7)

Country Link
US (2) US20070128174A1 (en)
EP (1) EP1996013A4 (en)
JP (1) JP2009508650A (en)
KR (2) KR20130066707A (en)
AU (1) AU2006292203A1 (en)
CA (1) CA2663749A1 (en)
WO (1) WO2007035843A2 (en)

Families Citing this family (141)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070025958A1 (en) 2000-10-27 2007-02-01 Hadden John W Vaccine immunotherapy
MXPA03003638A (en) 2000-10-27 2004-01-26 Immuno Rx Inc Vaccine immunotherapy for immune suppressed patients.
AU2002340463A1 (en) * 2001-11-16 2003-06-10 Children's Medical Center Corporation Augmentation of organ function
US8308797B2 (en) 2002-01-04 2012-11-13 Colibri Heart Valve, LLC Percutaneously implantable replacement heart valve device and method of making same
US7811274B2 (en) 2003-05-07 2010-10-12 Portaero, Inc. Method for treating chronic obstructive pulmonary disease
US7426929B2 (en) 2003-05-20 2008-09-23 Portaero, Inc. Intra/extra-thoracic collateral ventilation bypass system and method
US7252086B2 (en) 2003-06-03 2007-08-07 Cordis Corporation Lung reduction system
US7377278B2 (en) 2003-06-05 2008-05-27 Portaero, Inc. Intra-thoracic collateral ventilation bypass system and method
US7682332B2 (en) 2003-07-15 2010-03-23 Portaero, Inc. Methods to accelerate wound healing in thoracic anastomosis applications
US8257715B1 (en) 2004-08-26 2012-09-04 University Of Notre Dame Tissue vaccines and uses thereof
US8220460B2 (en) 2004-11-19 2012-07-17 Portaero, Inc. Evacuation device and method for creating a localized pleurodesis
US7824366B2 (en) 2004-12-10 2010-11-02 Portaero, Inc. Collateral ventilation device with chest tube/evacuation features and method
WO2006091766A2 (en) 2005-02-24 2006-08-31 Jau-Nan Lee Human trophoblast stem cells and use thereof
US8728072B2 (en) 2005-05-12 2014-05-20 Aesculap Ag Electrocautery method and apparatus
US9339323B2 (en) 2005-05-12 2016-05-17 Aesculap Ag Electrocautery method and apparatus
US8696662B2 (en) 2005-05-12 2014-04-15 Aesculap Ag Electrocautery method and apparatus
US8104474B2 (en) 2005-08-23 2012-01-31 Portaero, Inc. Collateral ventilation bypass system with retention features
US8778360B2 (en) * 2005-10-27 2014-07-15 University Of Notre Dame Extracellular matrix cancer vaccine adjuvant
US8802113B2 (en) 2005-10-27 2014-08-12 University Of Notre Dame Extracellular matrix cancer vaccine adjuvant
US9308252B2 (en) * 2005-10-27 2016-04-12 Cook Biotech, Inc. Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins
US7406963B2 (en) 2006-01-17 2008-08-05 Portaero, Inc. Variable resistance pulmonary ventilation bypass valve and method
US8574229B2 (en) 2006-05-02 2013-11-05 Aesculap Ag Surgical tool
DK2046349T3 (en) * 2006-07-12 2015-12-21 Mesoblast Inc TREATMENT OF EXCESSIVE NEOVASCULARIZATION
US9254220B1 (en) * 2006-08-29 2016-02-09 Vasamed, Inc. Method and system for assessing severity and stage of peripheral arterial disease and lower extremity wounds using angiosome mapping
US7931641B2 (en) 2007-05-11 2011-04-26 Portaero, Inc. Visceral pleura ring connector
US8163034B2 (en) 2007-05-11 2012-04-24 Portaero, Inc. Methods and devices to create a chemically and/or mechanically localized pleurodesis
US8062315B2 (en) 2007-05-17 2011-11-22 Portaero, Inc. Variable parietal/visceral pleural coupling
CN103865871A (en) 2007-06-08 2014-06-18 韦克福里斯特大学健康科学院 Selective cell therapy for the treatment of renal failure
CA2702118A1 (en) * 2007-08-30 2009-03-12 President And Fellows Of Harvard College Compliant surface multi-well culture plate
DE102007044487A1 (en) * 2007-09-18 2009-04-02 Universität Leipzig Use of the Reverse Cell Differentiation Program (OCDP) to treat degenerated pathological organs
GB2453589A (en) * 2007-10-12 2009-04-15 King S College London Protease inhibition
GB0722650D0 (en) * 2007-11-19 2007-12-27 Ge Healthcare Ltd Novel imaging method
US8679176B2 (en) 2007-12-18 2014-03-25 Cormatrix Cardiovascular, Inc Prosthetic tissue valve
US8257434B2 (en) 2007-12-18 2012-09-04 Cormatrix Cardiovascular, Inc. Prosthetic tissue valve
US8870867B2 (en) 2008-02-06 2014-10-28 Aesculap Ag Articulable electrosurgical instrument with a stabilizable articulation actuator
US8336540B2 (en) 2008-02-19 2012-12-25 Portaero, Inc. Pneumostoma management device and method for treatment of chronic obstructive pulmonary disease
WO2009105432A2 (en) 2008-02-19 2009-08-27 Portaero, Inc. Devices and methods for delivery of a therapeutic agent through a pneumostoma
US8475389B2 (en) 2008-02-19 2013-07-02 Portaero, Inc. Methods and devices for assessment of pneumostoma function
US9283266B2 (en) * 2008-02-28 2016-03-15 University Of Notre Dame Metastasis inhibition preparations and methods
EP4074342A1 (en) * 2008-03-21 2022-10-19 Kolon Tissuegene, Inc. Treatment of intervertebral disc degeneration
AU2015203016A1 (en) * 2008-03-21 2015-07-02 Tissuegene, Inc. Treatment of intervertebral disc degeneration
WO2009146392A1 (en) * 2008-05-29 2009-12-03 Irx Therapeutics, Inc. Mechanism of action of primary cell derived biologic
US8114043B2 (en) 2008-07-25 2012-02-14 Baxter International Inc. Electromagnetic induction access disconnect sensor
DE102008036060A1 (en) * 2008-08-04 2010-02-25 Technische Universität Dresden Cell-based method and means for bone formation
ES2608974T3 (en) 2008-08-14 2017-04-17 Mesoblast International Sàrl Compositions of purified mesenchymal stem cells
WO2010021996A1 (en) * 2008-08-18 2010-02-25 Junta De Beneficiencia De Guayaquil Treatment of injuries to the central nervous system
WO2010021714A2 (en) 2008-08-20 2010-02-25 Anthrogenesis Corporation Improved cell composition and methods of making the same
GB0820492D0 (en) 2008-11-07 2008-12-17 Sportcell Cell compositions and uses thereof
CA2743459A1 (en) * 2008-11-12 2010-05-20 Tengion, Inc. Isolated renal cells and uses thereof
WO2010057015A1 (en) 2008-11-14 2010-05-20 Wake Forest University Health Sciences Kidney structures and methods of forming the same
AU2009314506B2 (en) * 2008-11-14 2015-07-23 Histogen, Inc. Extracellular matrix compositions for the treatment of cancer
WO2010057013A1 (en) * 2008-11-14 2010-05-20 Wake Forest University Health Sciences Selective cell therapy for the treatment of renal failure
JP4473926B1 (en) 2008-12-24 2010-06-02 株式会社ファンケル Evaluation method of skin darkening tendency by ultraviolet rays
US8347881B2 (en) 2009-01-08 2013-01-08 Portaero, Inc. Pneumostoma management device with integrated patency sensor and method
US8518053B2 (en) 2009-02-11 2013-08-27 Portaero, Inc. Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease
WO2010132867A1 (en) 2009-05-15 2010-11-18 Irx Therapeutics, Inc. Vaccine immunotherapy
JP5889797B2 (en) 2009-12-08 2016-03-22 アイアールエックス セラピューティクス， インコーポレイテッド Methods to reverse the immunosuppression of Langerhans cells
US8846059B2 (en) * 2009-12-08 2014-09-30 University Of Notre Dame Extracellular matrix adjuvant and methods for prevention and/or inhibition of ovarian tumors and ovarian cancer
US20110150934A1 (en) * 2009-12-18 2011-06-23 University Of Notre Dame Ovarian Tumor Tissue Cell Preparations/Vaccines for the Treatment/Inhibition of Ovarian Tumors and Ovarian Cancer
RU2012103483A (en) 2010-02-04 2014-03-10 Эскулап Аг LAPAROSCOPIC RADIO FREQUENCY SURGICAL DEVICE
IL204116A (en) * 2010-02-23 2013-10-31 Sheltagen Medical Ltd Three-dimensional bone implant and method for producing same
CA2800232C (en) 2010-03-01 2015-08-11 Colibri Heart Valve Llc Percutaneously deliverable heart valve and methods associated therewith
US8827992B2 (en) 2010-03-26 2014-09-09 Aesculap Ag Impedance mediated control of power delivery for electrosurgery
US8419727B2 (en) 2010-03-26 2013-04-16 Aesculap Ag Impedance mediated power delivery for electrosurgery
JP5220791B2 (en) * 2010-03-29 2013-06-26 株式会社マンダム Melanin production inducer and test substance evaluation method
KR102223564B1 (en) 2010-05-12 2021-03-05 인리젠 Bioactive renal cells
CN103153384B (en) 2010-06-28 2016-03-09 科利柏心脏瓣膜有限责任公司 For the device of device in the delivery of vascular of chamber
US9173698B2 (en) 2010-09-17 2015-11-03 Aesculap Ag Electrosurgical tissue sealing augmented with a seal-enhancing composition
US9622911B2 (en) 2010-09-30 2017-04-18 Cxl Ophthalmics, Llc Ophthalmic treatment device, system, and method of use
KR101224504B1 (en) * 2010-10-01 2013-01-22 가톨릭대학교 산학협력단 Novel use of cryptotanshinone
WO2012054301A1 (en) * 2010-10-20 2012-04-26 Tautona Group Lp Soft tissue augmentation threads and methods of use thereof
KR102056324B1 (en) 2010-11-10 2019-12-16 인리젠 Injectable formulations for organ augmentation
GB2502704B (en) 2010-11-15 2019-12-04 Accelerated Biosciences Corp Generation of neural stem cells from human trophoblast stem cells
TWI582234B (en) * 2010-11-15 2017-05-11 zhao-nan Li Generation of neural stem cells from human trophoblast stem cells
US9737400B2 (en) 2010-12-14 2017-08-22 Colibri Heart Valve Llc Percutaneously deliverable heart valve including folded membrane cusps with integral leaflets
JP5643078B2 (en) * 2010-12-27 2014-12-17 株式会社ニデック Eye refractive power measuring device
PT2667878E (en) * 2011-01-25 2016-06-03 Univ Catholique Louvain Compositions and methods for cell transplantation
US9585930B2 (en) 2011-03-20 2017-03-07 Trustees Of Boston University Therapeutic agent for emphysema and COPD
AU2012262549B2 (en) 2011-05-27 2016-02-11 Cormatrix Cardiovascular, Inc. Extracellular matrix material valve conduit and methods of making thereof
EP2713943A4 (en) * 2011-05-31 2014-12-17 Cormatrix Cardiovascular Inc Compositions for preventing cardiac arrhythmia
RU2469676C1 (en) * 2011-05-31 2012-12-20 Российская Федерация, от имени которой выступает Министерство промышленности и торговли Российской Федерации (Минпромторг России) Method for targeted delivery of osteoplastic materials containing bone growth and regeneration factors into alveolar bone defect
MX349146B (en) * 2011-06-13 2017-07-14 Univ Illinois Peptide compositions and methods for treating lung injury, asthma, anaphylaxis, angioedema, systemic vascular permeability syndromes, and nasal congestion.
RU2461359C1 (en) * 2011-06-16 2012-09-20 Федеральное государственное учреждение "Центральный научно-исследовательский институт стоматологии и челюстно-лицевой хирургии" Министерства здравоохранения и социального развития Российской Федерации Method for relieving glossoplegia
US9339327B2 (en) 2011-06-28 2016-05-17 Aesculap Ag Electrosurgical tissue dissecting device
WO2013059644A1 (en) * 2011-10-21 2013-04-25 Baylor College Of Medicine Method to measure inflammation in the conjunctiva of patients with tear dysfunction
KR20140103122A (en) * 2011-11-17 2014-08-25 넨키 인스티튜트 오브 익스페리멘탈 바이올로지 Compositions and methods for treating glioma
EP2806879B1 (en) 2012-01-25 2019-03-06 Université Catholique de Louvain Compositions and methods for cell transplantation
RU2644933C2 (en) * 2012-03-08 2018-02-14 Медтроник Аф Люксембург Сарл Biomarker samples selection as part of devices for neuromodulation and relevant systems and methods
WO2013149075A1 (en) 2012-03-29 2013-10-03 Cxl Ophthalmics, Llc Compositions and methods for treating or preventing diseases associated with oxidative stress
WO2013148895A1 (en) 2012-03-29 2013-10-03 Cxl Ophthalmics, Llc Ocular cross-linking system and method for sealing corneal wounds
WO2013148896A1 (en) 2012-03-29 2013-10-03 Cxl Ophthalmics, Llc Ocular treatment solutions, delivery devices and delivery augmentation methods
US20130317412A1 (en) * 2012-05-23 2013-11-28 Bruno Dacquay Flow Control For Treating A Medical Condition
CA2875786C (en) * 2012-06-08 2022-12-06 Janssen Biotech, Inc. Differentiation of human embryonic stem cells into pancreatic endocrine cells
US20140030309A1 (en) * 2012-07-11 2014-01-30 Osiris Therapeutics, Inc. Disrupted cartilage products
CN107252347B (en) 2012-09-26 2019-10-29 蛇牌股份公司 Equipment for organizing to cut and seal
AU2013352307B2 (en) 2012-11-30 2018-11-15 Accelerated Biosciences Corp. Methods of differentiating stem cells by modulating miR-124
WO2014105546A1 (en) * 2012-12-31 2014-07-03 Janssen Biotech, Inc. Differentiation of human embryonic stem cells into pancreatic endocrine cells using hb9 regulators
ES2712719T3 (en) 2013-02-06 2019-05-14 Nc Medical Res Inc Method of production of a heterogeneous subpopulation of bone marrow cells suitable for the treatment of neurodegeneration caused by an ischemic stroke
US10966640B2 (en) * 2013-02-26 2021-04-06 db Diagnostic Systems, Inc. Hearing assessment system
US9826924B2 (en) * 2013-02-26 2017-11-28 db Diagnostic Systems, Inc. Hearing assessment method and system
WO2014134532A1 (en) * 2013-02-28 2014-09-04 Ventrix, Inc. Methods and compositions for tissue therapy and analysis
US11207352B2 (en) 2013-03-15 2021-12-28 Avita International Ltd. Compositions comprising stem cells expressing mesenchymal and neuronal markers and uses thereof to treat neurological disease
US9790468B2 (en) 2013-03-15 2017-10-17 Avita Iinternational Ltd. Multifunctional immature dental pulp stem cells and therapeutic applications
WO2014203269A2 (en) * 2013-06-17 2014-12-24 Kasiak Research Pvt. Ltd. Method for isolation, purification and industrial scale expansion of canine adipose tissue derived mesenchymal stem cells
EP3016665B1 (en) 2013-07-05 2019-09-18 Université Catholique de Louvain Conditioned medium from human adult liver stem cells and its use in the treatment of liver disorders
CA2919324A1 (en) * 2013-07-26 2015-01-29 Kenta Yamamoto Osteoblast and method for preparing same
EP3549591B1 (en) * 2013-09-05 2021-11-03 The Regents of The University of California Adipose-derived mesenchymal stem cells for stomatitis treatment
US20160220612A1 (en) * 2013-09-06 2016-08-04 Consejo Nacional De Investigaciones Cientificas Y Tecnicas (Conicet) Compositions and methods for increasing mesenchymal stromal cell migration to tumors
WO2015041606A1 (en) * 2013-09-17 2015-03-26 Singapore Health Services Pte Ltd Corneal stromal keratocyte culture
CA2930556A1 (en) 2013-11-14 2015-05-21 Dermarche Labs, Llc Fibroblast mixtures and methods of making and using the same
GB201403773D0 (en) 2014-03-04 2014-04-16 Univ Cardiff Microneedle based cell delivery
US20170124701A1 (en) * 2014-03-17 2017-05-04 Arizona Board Of Regents On Behalf Of Arizona State University System and method for measuring artery thickness using ultrasound imaging
JP6304818B2 (en) * 2014-04-21 2018-04-04 花王株式会社 Method for producing skin-derived pluripotent progenitor cells
CA2946761C (en) * 2014-05-08 2023-08-22 Wake Forest University Health Sciences Methods of treating incontinence and other sphincter deficiency disorders
US11253549B2 (en) 2014-05-23 2022-02-22 JangoBio, LLC Methods to rebalance the hypothalamic-pituitary-gonadal axis
US11439668B2 (en) 2014-05-23 2022-09-13 JangoBio, LLC Methods to differentiate stem cells into hormone-producing cells
ES2907551T3 (en) * 2014-10-20 2022-04-25 Astute Medical Inc Methods and compositions for the diagnosis and prognosis of kidney injury and kidney failure
JP6836990B2 (en) 2014-11-26 2021-03-03 アクセラレイテッド・バイオサイエンシズ・コーポレーション Induced hepatocytes and their use
AU2014277667B2 (en) * 2014-12-15 2022-07-14 The University Of Queensland Differentiation of pluripotent stem cells to form renal organoids
WO2016149317A1 (en) * 2015-03-19 2016-09-22 Restore Health, Inc. Treatment for vesicovaginal fistula
US10470839B2 (en) 2016-06-02 2019-11-12 Covidien Lp Assessment of suture or staple line integrity and localization of potential tissue defects along the suture or staple line
US11123372B2 (en) 2016-07-29 2021-09-21 Prokidney Bioactive renal cells for the treatment of chronic kidney disease
KR20190055088A (en) * 2016-08-19 2019-05-22 리젠티스 코퍼레이션 Extracellular matrix for tissue remodeling of mucosal tissue
US10548908B2 (en) * 2016-09-15 2020-02-04 Nostopharma, LLC Compositions and methods for preventing and treating heterotopic ossification and pathologic calcification
US11266676B2 (en) 2016-10-27 2022-03-08 The Regents Of The University Of California MicroRNA in T cell activation
US11395726B2 (en) 2017-09-11 2022-07-26 Incubar Llc Conduit vascular implant sealing device for reducing endoleaks
GB2566516A (en) 2017-09-15 2019-03-20 Univ Oxford Innovation Ltd Electrochemical recognition and quantification of cytochrome c oxidase expression in bacteria
CN111601606A (en) * 2017-11-29 2020-08-28 菲格内有限责任公司 Interaction of fibroblasts with immune cells for activation and uses thereof
CN108324993B (en) * 2018-01-15 2020-11-03 朱剑虹 Stem cell complex for inducing hair regeneration, preparation method and application thereof
KR102025554B1 (en) * 2018-04-05 2019-09-26 단국대학교 천안캠퍼스 산학협력단 Composition for differentiation of dental epithelial cells to ameloblast
CN108517313B (en) * 2018-04-17 2021-06-01 郭子宽 Serum/plasma substitute for culturing and amplifying dental pulp stem cells
US20220000934A1 (en) * 2018-11-04 2022-01-06 Figene, Llc Methods and compositions for treatment of type 1 diabetes using fibroblasts as facilitators of islet engraftment
WO2020123312A1 (en) 2018-12-09 2020-06-18 Weinberg Assa Method to prevent and treat macular degeneration by vasodilators
WO2020123852A1 (en) * 2018-12-15 2020-06-18 Weinberg Assa Method to prevent and treat ocular cataract by calcium channel blockers, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers
WO2021055014A1 (en) * 2019-09-20 2021-03-25 President And Fellows Of Harvard College Methods and compositions for reducing hair greying
US20220395538A1 (en) * 2019-11-17 2022-12-15 Figene, Llc Fibroblast-based therapy for treatment and prevention of stroke
CN111145899B (en) * 2019-11-26 2020-10-20 天津医科大学眼科医院 Method for estimating degree of change of equivalent sphere power before and after cycloplegia
KR102251640B1 (en) * 2019-11-27 2021-05-17 서울대학교산학협력단 Peptides for promoting adipocyte differentiation and composition for promoting adipocyte differentiation comprising the same
JPWO2022113667A1 (en) * 2020-11-27 2022-06-02
EP4333753A1 (en) * 2021-05-05 2024-03-13 Cedars-Sinai Medical Center Uv a light exposure increases mitochondrial anti-viral protein expression in tracheal cells via cell-to-cell communication and uses thereof
CN113398248B (en) * 2021-07-27 2023-08-15 上海交通大学医学院附属第九人民医院 External medicine for improving skin flap blood circulation and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863531A (en) * 1986-04-18 1999-01-26 Advanced Tissue Sciences, Inc. In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
US6355239B1 (en) * 1998-03-13 2002-03-12 Osiris Therapeutics, Inc. Uses for non-autologous mesenchymal stem cells
US6878383B2 (en) * 1998-05-22 2005-04-12 Isolagen Technologies, Inc. Compositions for regenerating tissue that has deteriorated, and methods for using such compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767452B2 (en) * 1997-02-20 2010-08-03 Kleinsek Don A Tissue treatments with adipocyte cells
WO1999043270A1 (en) * 1998-02-24 1999-09-02 Gerigene Medical Corporation Augmentation and repair of dermal, subcutaneous, and vocal cord tissue defects
AU771701B2 (en) * 1998-08-14 2004-04-01 Genzyme Corporation Methods, instruments and materials for chondrocyte cell transplantation
JP2003517858A (en) * 1999-11-05 2003-06-03 ジェリジーン メディカル コーポレーション Augmentation and repair of age-related soft tissue defects
US7575743B2 (en) * 2001-01-30 2009-08-18 Orthogene, Inc. Compositions and methods for the treatment and repair of defects or lesions in articular cartilage using synovial-derived tissue or cells
US7651684B2 (en) * 2001-12-07 2010-01-26 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in augmenting autologous fat transfer

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863531A (en) * 1986-04-18 1999-01-26 Advanced Tissue Sciences, Inc. In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
US6355239B1 (en) * 1998-03-13 2002-03-12 Osiris Therapeutics, Inc. Uses for non-autologous mesenchymal stem cells
US6878383B2 (en) * 1998-05-22 2005-04-12 Isolagen Technologies, Inc. Compositions for regenerating tissue that has deteriorated, and methods for using such compositions

Also Published As

Publication number Publication date
US20070128174A1 (en) 2007-06-07
KR20130066707A (en) 2013-06-20
CA2663749A1 (en) 2007-03-29
JP2009508650A (en) 2009-03-05
US20110081323A1 (en) 2011-04-07
WO2007035843A2 (en) 2007-03-29
EP1996013A4 (en) 2010-03-10
EP1996013A2 (en) 2008-12-03
AU2006292203A1 (en) 2007-03-29
KR20080075494A (en) 2008-08-18

Similar Documents

Publication Publication Date Title
WO2007035843A3 (en) Methods and compositions for organ and tissue functionality
EP2418271A3 (en) Methods and compositions for treatment of bone defects with placental cell populations
WO2012002986A3 (en) Decellularized and delipidized extracellular matrix and methods of use
AU2005221582A8 (en) Tissue repair with multipotent cells
WO2008036374A3 (en) Allogeneic stem cell transplants in non-conditioned recipients
WO2006093857A3 (en) Method of providing readily available cellular material derived from peripheral blood and a composition thereof
WO2007035363A3 (en) Compositions and methods for the augmentation and repair of defects in tissue
WO2009045360A3 (en) Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
WO2006081435A3 (en) Method of providing readily available cellular material derived from cord blood, and a composition thereof
WO2010039823A3 (en) Compositions and methods for tissue repair with extracellular matrices
WO2004009767A3 (en) Cell therapy for regeneration
WO2006118914A3 (en) Methods of increasing proliferation of adult mammalian cardiomyocytes through p38 map kinase inhibition
EP2465921A3 (en) Cardiac stem cells from biopsy
EP2003196A3 (en) Compositions and methods for treating and diagnosing cancer
EP1958651A3 (en) Viable tissue repair implants and methods of use
EP2243826A3 (en) Mesenchymal stem cells and uses therefor
GB2434105A (en) Fibronectin-modified ECM tissue graft constructs and methods for preparation and use thereof
WO2010072417A3 (en) Rapid preparation and use of engineered tissue and scaffolds as individual implants
WO2005112542A3 (en) Cartilage and bone repair composition
SG152297A1 (en) Composition for stimulating bone growth and differentiation and method for isolating same
EP2641911A3 (en) Compositions and methods for re-programming cells without genetic modification
HK1139878A1 (en) Method for the treatment of biological tissue of animal or human origin, such as porcine or bovine pericardium or human cadaver heart valves, and biological tissue treated accordingly
WO2009086305A3 (en) Osteoinductive putties and methods of making and using such putties
WO2011011482A3 (en) Variable density tissue graft composition and methods of making and using the same
WO2009047568A3 (en) In vitro preservation of living animal cells and compounds suitable for use in the preservation of living animal cells

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)
ENP Entry into the national phase

Ref document number: 2008532366

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2006803955

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2006292203

Country of ref document: AU

Ref document number: 1020087009566

Country of ref document: KR

ENP Entry into the national phase

Ref document number: 2006292203

Country of ref document: AU

Date of ref document: 20060921

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2663749

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1020137013495

Country of ref document: KR